Hilde Lysvand

Trondheim, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Clinical manifestations in children with parechovirus A and respiratory tract infection.

Clinical manifestations in children with parechovirus A and respiratory tract infection.

Journal: Frontiers in pediatrics

Published: February 26, 2026

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.

Journal: NAR molecular medicine

Published: October 31, 2025

JAK inhibitors remove innate immune barriers facilitating viral propagation.

JAK inhibitors remove innate immune barriers facilitating viral propagation.

Journal: NAR molecular medicine

Published: March 14, 2025

Clinical Manifestations and Viral Codetections in Infants With Parechovirus A.

Clinical Manifestations and Viral Codetections in Infants With Parechovirus A.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: February 27, 2025

Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures.

Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures.

Journal: Cellular and molecular life sciences : CMLS

Published: July 25, 2024

The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.

The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.

Journal: Antiviral research

Published: January 03, 2024

Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study.

Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: September 21, 2023

Detection of subgenomic mRNA from endemic human coronavirus OC43 and NL63 compared to viral genomic loads, single virus detection and clinical manifestations in children with respiratory tract infections.

Detection of subgenomic mRNA from endemic human coronavirus OC43 and NL63 compared to viral genomic loads, single virus detection and clinical manifestations in children with respiratory tract infections.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: April 29, 2022

The Streptococcus agalactiae R3 surface protein is encoded by sar5.

The Streptococcus agalactiae R3 surface protein is encoded by sar5.

Journal: PloS one

Published: January 07, 2022

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections.

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections.

Journal: Viruses

Published: November 12, 2021

Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2.

Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2.

Journal: Viruses

Published: August 10, 2021

Active Components of Commonly Prescribed Medicines Affect Influenza A Virus-Host Cell Interaction: A Pilot Study.

Active Components of Commonly Prescribed Medicines Affect Influenza A Virus-Host Cell Interaction: A Pilot Study.

Journal: Viruses

Published: July 09, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026